Wendy Verhoek-Ofstedhl Phd is categorized under Medical Research in Oakland, RI and active since 1995.
Wendy Verhoek-Ofstedhl Phd was established in 1995, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Wendy Verhoek-Ofstedhl Phd at the company’s single location by writing to 1168 Victory Highway, Oakland, Rhode Island RI 02858 or by phoning (401) 568-0815. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Wendy Verhoek-Ofstedhl Phd |
| Contact Person: | Wendy Verhoek-Ofstedhl Phd |
| Address: | 1168 Victory Highway, Oakland, Rhode Island 02858 |
| Phone Number: | (401) 568-0815 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Wendy Verhoek-Ofstedhl Phd was started in 1995 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Wendy Verhoek-Ofstedhl Phd for inquiries that concern Wendy Verhoek-Ofstedhl Phd by calling the company number (401) 568-0815, as your correspondence is most welcome. Additionally, the physical location of the single location of Wendy Verhoek-Ofstedhl Phd can be found at the coordinates 41.957767,-71.647328 as well as the street address 1168 Victory Highway in Oakland, Rhode Island 02858.
For its online presence, you may visit Wendy Verhoek-Ofstedhl Phd’s website at and engage with its social media outlets through on Twitter and on Facebook.